S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2 RANDOMIZED ROSEWOOD TRIAL - P. L. Zinzani; J. Mayer; R. Auer; F. Bijou; A. C. de Oliveira; C. R. Flowers; M. Merli; K. Bouabdallah; P. S. Ganly; Y. Song; H. Zhang; R. Johnson; et al. (HemaSphere, 2022)